Distributions of High-Sensitivity C-Reactive Protein, Total Cholesterol-HDL Ratio and 10-Year Cardiovascular Risk: National Population-Based Study [0.03%]
高敏感性C-反应蛋白、总胆固醇-高密度脂蛋白比值和10年心血管风险分布：一项全国基于人群的研究
Alipasha Meysamie,Saeed Ghodsi,Reza Ghalehtaki et al.
Alipasha Meysamie et al.
The present study aimed to evaluate the distributions of High-Sensitivity C-reactive protein, TC-HDL ratio and 10-year risk of cardiovascular diseases among Iranian adult population. We conducted a cross-sectional study on a total of 2125 a...
Pooneh Salari,Bagher Larijani
Pooneh Salari
More than a decade ago, personalized medicine was presented in modern medicine. Personalized medicine means that the right drug should be prescribed for the right patient based on genetic data. No doubt is developing medical sciences, and i...
Precision Medicine Approach to Anaplastic Thyroid Cancer: Advances in Targeted Drug Therapy Based on Specific Signaling Pathways [0.03%]
甲状腺癌精确诊疗进展：基于特定信号通路的靶向药物治疗
Hilda Samimi,Parviz Fallah,Alireza Naderi Sohi et al.
Hilda Samimi et al.
Personalized medicine is a set of diagnostic, prognostic and therapeutic approaches in which medical interventions are carried out based on individual patient characteristics. As life expectancy increases in developed and developing countri...
Ali Hosseini Bereshneh,Fatemeh Morshedi,Mahsa Hematyar et al.
Ali Hosseini Bereshneh et al.
Pancreatic cancer (PC) is a progressive, fatal disease with a high degree of malignancy. More than 40000 peoplediefrom this cancer annually in the United States. As a multifactorial condition, PC has a complex nature, and there are several ...
The Potential of Circulating Tumor Cells in Personalized Management of Breast Cancer: A Systematic Review [0.03%]
循环肿瘤细胞在乳腺癌个体化治疗中的潜力：系统综述
Fatemeh Khatami,Hamid Reza Aghayan,Maryam Sanaei et al.
Fatemeh Khatami et al.
Circulating tumor cells (CTCs) recognition and characterization in the peripheral blood of patients with breast cancer have proven practical and predictive value in different studies. However, the clinical significance of CTCs enumeration a...
Path to Personalized Medicine for Type 2 Diabetes Mellitus: Reality and Hope [0.03%]
2型糖尿病的精准医疗之路：现状与希望
Hamid Reza Aghaei Meybodi,Mandana Hasanzad,Bagher Larijani
Hamid Reza Aghaei Meybodi
Type 2 diabetes mellitus (T2DM) is recognized as a public health problem and increasingly prevalent illness. Key elements of the guideline for diabetes care are based on evidence-based medicine approach and apply for population, not individ...
Somayeh Mirsadeghi,Bagher Larijani
Somayeh Mirsadeghi
Personalized medicine aims is to supply the proper drug to the proper patient within the right dose. Pharmacogenomics (PGx) is to recognize genetic variants that may influence drug efficacy and toxicity. All things considered, the fields co...
Babak Arjmand,Parisa Goodarzi,Fereshteh Mohamadi-Jahani et al.
Babak Arjmand et al.
Personalized medicine as a novel field of medicine refers to the prescription of specific therapeutics procedure for an individual. This approach has established based on pharmacogenetic and pharmacogenomic information and data. The terms p...
Babak Arjmand,Bagher Larijani
Babak Arjmand
Treatment of an Early Kaposi's Sarcoma Case Post Kidney Transplantation by Sirolimus: A Case Report [0.03%]
依维莫司治疗1例肾移植术后早期卡波西肉瘤患者——个案报告
Farzaneh Najafi,Parichehr Kafaie,Hossein Neamatzadeh
Farzaneh Najafi
Kaposi᾽s sarcoma (KS) can develop in 0.06% to 4.1% of kidney transplant recipients. Here we describe a case of 50-year-old man who developed KS a few months after kidney transplantation. After transplantation, he had delayed graft function...
Case Reports
Acta medica Iranica. 2017 Feb;55(2):139-141. DOI: 2017